House Dust Mite and Cat Dander Extract Induce Asthma-Like Histopathology with an Increase of Mucosal Mast Cells in a Guinea Pig Model.
Journal
Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
10
2022
revised:
09
01
2023
accepted:
10
01
2023
entrez:
10
2
2023
pubmed:
11
2
2023
medline:
14
2
2023
Statut:
epublish
Résumé
Asthma is a chronic inflammatory disease with structural changes in the lungs defined as airway remodelling. Mast cell responses are important in asthma as they, upon activation, release mediators inducing bronchoconstriction, inflammatory cell recruitment, and often remodelling of the airways. As guinea pigs exhibit anatomical, physiological, and pharmacological features resembling human airways, including mast cell distribution and mediator release, we evaluated the effect of extracts from two common allergens, house dust mite (HDM) and cat dander (CDE), on histopathological changes and the composition of tryptase- and chymase-positive mast cells in the guinea pig lungs. Guinea pigs were exposed intranasally to HDM or CDE for 4, 8, and 12 weeks, and airway histology was examined at each time point. Hematoxylin and eosin, Picro-Sirius Red, and Periodic Acid-Schiff staining were performed to evaluate airway inflammation, collagen deposition, and mucus-producing cells. In addition, Astra blue and immunostaining against tryptase and chymase were used to visualize mast cells. Repetitive administration of HDM or CDE led to the accumulation of inflammatory cells into the proximal and distal airways as well as increased airway smooth muscle mass. HDM exposure caused subepithelial collagen deposition and mucus cell hyperplasia at all three time points, whereas CDE exposure only caused these effects at 8 and 12 weeks. Both HDM and CDE induced a substantial increase in mast cells after 8 and 12 weeks of challenges. This increase was primarily due to mast cells expressing tryptase, but not chymase, thus indicating mucosal mast cells. We here show that exposure to HDM and CDE elicits asthma-like histopathology in guinea pigs with infiltration of inflammatory cells, airway remodelling, and accumulation of primarily mucosal mast cells. The results together encourage the use of HDM and CDE allergens for the stimulation of a clinically relevant asthma model in guinea pigs.
Sections du résumé
Background
UNASSIGNED
Asthma is a chronic inflammatory disease with structural changes in the lungs defined as airway remodelling. Mast cell responses are important in asthma as they, upon activation, release mediators inducing bronchoconstriction, inflammatory cell recruitment, and often remodelling of the airways. As guinea pigs exhibit anatomical, physiological, and pharmacological features resembling human airways, including mast cell distribution and mediator release, we evaluated the effect of extracts from two common allergens, house dust mite (HDM) and cat dander (CDE), on histopathological changes and the composition of tryptase- and chymase-positive mast cells in the guinea pig lungs.
Methods
UNASSIGNED
Guinea pigs were exposed intranasally to HDM or CDE for 4, 8, and 12 weeks, and airway histology was examined at each time point. Hematoxylin and eosin, Picro-Sirius Red, and Periodic Acid-Schiff staining were performed to evaluate airway inflammation, collagen deposition, and mucus-producing cells. In addition, Astra blue and immunostaining against tryptase and chymase were used to visualize mast cells.
Results
UNASSIGNED
Repetitive administration of HDM or CDE led to the accumulation of inflammatory cells into the proximal and distal airways as well as increased airway smooth muscle mass. HDM exposure caused subepithelial collagen deposition and mucus cell hyperplasia at all three time points, whereas CDE exposure only caused these effects at 8 and 12 weeks. Both HDM and CDE induced a substantial increase in mast cells after 8 and 12 weeks of challenges. This increase was primarily due to mast cells expressing tryptase, but not chymase, thus indicating mucosal mast cells.
Conclusions
UNASSIGNED
We here show that exposure to HDM and CDE elicits asthma-like histopathology in guinea pigs with infiltration of inflammatory cells, airway remodelling, and accumulation of primarily mucosal mast cells. The results together encourage the use of HDM and CDE allergens for the stimulation of a clinically relevant asthma model in guinea pigs.
Identifiants
pubmed: 36761882
doi: 10.1155/2023/9393497
pmc: PMC9904926
doi:
Substances chimiques
Allergens
0
Tryptases
EC 3.4.21.59
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9393497Informations de copyright
Copyright © 2023 Patricia Ramos-Ramírez et al.
Déclaration de conflit d'intérêts
None of the authors has any conflict of interest.
Références
Proc Am Thorac Soc. 2004;1(3):176-83
pubmed: 16113432
Thorax. 2009 Apr;64(4):297-305
pubmed: 19131451
Eur J Immunol. 1998 Mar;28(3):1022-33
pubmed: 9541598
Clin Exp Allergy. 2009 May;39(5):740-51
pubmed: 19302253
Curr Opin Immunol. 2018 Feb;50:39-47
pubmed: 29144996
J Allergy Clin Immunol. 2011 Apr;127(4):905-12.e1-7
pubmed: 21388666
Eur Respir J. 2006 Sep;28(3):603-11
pubmed: 16737991
Cell Tissue Res. 2017 Mar;367(3):551-569
pubmed: 28190087
Proc Natl Acad Sci U S A. 1986 Jun;83(12):4464-8
pubmed: 3520574
Clin Sci (Lond). 2020 Jun 12;134(11):1219-1242
pubmed: 32501497
Int Arch Allergy Immunol. 2014;165(3):195-205
pubmed: 25531229
Br J Pharmacol. 2013 Sep;170(1):200-13
pubmed: 23734568
Pediatr Allergy Immunol. 1999 Nov;10(4):258-60
pubmed: 10678722
J Allergy Clin Immunol. 1994 Jun;93(6):1021-30
pubmed: 8006307
J Clin Invest. 1996 Nov 15;98(10):2284-91
pubmed: 8941645
Int Immunopharmacol. 2007 Feb;7(2):183-90
pubmed: 17178385
Nat Med. 2009 Apr;15(4):410-6
pubmed: 19330007
Pulm Pharmacol Ther. 2013 Oct;26(5):532-9
pubmed: 23583635
Am J Respir Crit Care Med. 2012 Sep 15;186(6):501-7
pubmed: 22773731
Clin Exp Allergy. 2020 Oct;50(10):1184-1195
pubmed: 32691918
Pediatr Pulmonol. 2018 Jun;53(6):824-835
pubmed: 29469196
Eur J Immunol. 1998 Nov;28(11):3730-7
pubmed: 9842915
J Immunol. 2013 Aug 15;191(4):1529-35
pubmed: 23878318
N Engl J Med. 2002 May 30;346(22):1699-705
pubmed: 12037149
Clin Sci (Lond). 2013 Dec;125(11):533-42
pubmed: 23799245
Cell Immunol. 1999 Mar 15;192(2):185-93
pubmed: 10087187
Am J Respir Crit Care Med. 2011 Feb 1;183(3):299-309
pubmed: 20813890
Am Rev Respir Dis. 1990 Aug;142(2):434-57
pubmed: 2200318
PLoS One. 2017 Oct 31;12(10):e0187249
pubmed: 29088265
Allergy. 2012 Jul;67(7):958-61
pubmed: 22583078
J Cell Mol Med. 2008 Dec;12(6A):2381-94
pubmed: 18266975
Trends Immunol. 2011 Sep;32(9):402-11
pubmed: 21783420
Adv Exp Med Biol. 2016;905:87-95
pubmed: 26987338
Biochem Pharmacol. 2010 Oct 1;80(7):1033-41
pubmed: 20599788
J Allergy Clin Immunol. 2001 Jul;108(1):116-21
pubmed: 11447391
Clin Exp Allergy. 2016 Feb;46(2):194-263
pubmed: 26567481
Allergy Asthma Clin Immunol. 2018 Apr 10;14:14
pubmed: 29643919